0001104659-23-003861.txt : 20230113 0001104659-23-003861.hdr.sgml : 20230113 20230113170058 ACCESSION NUMBER: 0001104659-23-003861 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220314 FILED AS OF DATE: 20230113 DATE AS OF CHANGE: 20230113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Khattar Jack A. CENTRAL INDEX KEY: 0001539937 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 23529397 MAIL ADDRESS: STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC. STREET 2: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060317 4/A 1 tm233200-2_4aseq1.xml OWNERSHIP DOCUMENT X0306 4/A 2022-03-14 2022-03-17 0 0001356576 SUPERNUS PHARMACEUTICALS, INC. SUPN 0001539937 Khattar Jack A. C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850 1 1 0 0 President, CEO Common Stock 2022-03-14 4 M 0 40000 0 A 556466 D Common Stock 2022-03-14 4 A 0 20000 0 A 576466 D Common Stock 1058450 I By the KBT Trust Common Stock 4000 I By Son Performance Share Unit 0 2022-03-14 4 M 0 40000 0 D 2031-02-19 Common Stock 40000 0 D Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on February 19, 2021. The Reporting Person disclaims beneficial ownership of the shares held by his son, who shares the Reporting Person's household, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. On February 19, 2021, the Reporting Person was awarded Performance Shares Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period. /s/ Timothy C. Dec, as attorney-in-fact 2023-01-13